Wang et al.'s (2021) study reported that PTX improved cognitive deficits in aging mice through Nrf2/PGC‐1a activation; in our study, PTX improved proteinuria, tubulointerstitial fibrosis, and microvascular rarefaction in aging mouse kidney. The gene discussed is PPARGC1A; the disease is Cognitive impairment.